Matches in Wikidata for { <http://www.wikidata.org/entity/Q89468085> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q89468085 description "article scientifique publié en 2020" @default.
- Q89468085 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q89468085 description "scientific article published on 29 January 2020" @default.
- Q89468085 description "wetenschappelijk artikel" @default.
- Q89468085 description "наукова стаття, опублікована 29 січня 2020" @default.
- Q89468085 name "The protective effects of dulaglutide against advanced glycation end products (AGEs)-induced degradation of type Ⅱ collagen and aggrecan in human SW1353 chondrocytes" @default.
- Q89468085 name "The protective effects of dulaglutide against advanced glycation end products (AGEs)-induced degradation of type Ⅱ collagen and aggrecan in human SW1353 chondrocytes" @default.
- Q89468085 type Item @default.
- Q89468085 label "The protective effects of dulaglutide against advanced glycation end products (AGEs)-induced degradation of type Ⅱ collagen and aggrecan in human SW1353 chondrocytes" @default.
- Q89468085 label "The protective effects of dulaglutide against advanced glycation end products (AGEs)-induced degradation of type Ⅱ collagen and aggrecan in human SW1353 chondrocytes" @default.
- Q89468085 prefLabel "The protective effects of dulaglutide against advanced glycation end products (AGEs)-induced degradation of type Ⅱ collagen and aggrecan in human SW1353 chondrocytes" @default.
- Q89468085 prefLabel "The protective effects of dulaglutide against advanced glycation end products (AGEs)-induced degradation of type Ⅱ collagen and aggrecan in human SW1353 chondrocytes" @default.
- Q89468085 P1433 Q89468085-D6562AF2-47D7-4E62-A1EC-3D19E43DF7E0 @default.
- Q89468085 P1476 Q89468085-B18596C8-602C-4459-8594-66CAB082FE38 @default.
- Q89468085 P2093 Q89468085-32AB84B0-9705-4B54-83F1-355EAAE1B768 @default.
- Q89468085 P2093 Q89468085-58239F0F-3BFE-4C31-8948-575E7E9712D1 @default.
- Q89468085 P2093 Q89468085-86AE558C-03DA-4935-A384-74DE0CECF5C6 @default.
- Q89468085 P2093 Q89468085-8A5CF592-BB51-4C3A-975A-748A09A9090C @default.
- Q89468085 P304 Q89468085-CF7DA514-1677-43A2-917C-327F39BD6ED0 @default.
- Q89468085 P31 Q89468085-4F09A567-B84F-475D-840A-32E4A842133A @default.
- Q89468085 P356 Q89468085-D572DD94-5FB4-4C26-A536-4B039856A9BD @default.
- Q89468085 P478 Q89468085-F24547C8-D48F-4FD9-B536-EA9A86887DEC @default.
- Q89468085 P577 Q89468085-D144863C-3986-41D7-A731-7451AA1EB3AB @default.
- Q89468085 P698 Q89468085-3E5AD10E-ECAF-4074-8EFE-203979375CD8 @default.
- Q89468085 P356 J.CBI.2020.108968 @default.
- Q89468085 P698 32004530 @default.
- Q89468085 P1433 Q14923137 @default.
- Q89468085 P1476 "The protective effects of dulaglutide against advanced glycation end products (AGEs)-induced degradation of type Ⅱ collagen and aggrecan in human SW1353 chondrocytes" @default.
- Q89468085 P2093 "Biao Li" @default.
- Q89468085 P2093 "Hai Li" @default.
- Q89468085 P2093 "Jianhai Chen" @default.
- Q89468085 P2093 "Xiaoyan Fang" @default.
- Q89468085 P304 "108968" @default.
- Q89468085 P31 Q13442814 @default.
- Q89468085 P356 "10.1016/J.CBI.2020.108968" @default.
- Q89468085 P478 "322" @default.
- Q89468085 P577 "2020-01-29T00:00:00Z" @default.
- Q89468085 P698 "32004530" @default.